Literature DB >> 24283600

Screening for obstructive sleep apnea syndrome in hypertensive outpatients: clinical characteristics of hypertension are important for their analysis.

Tomoyuki Kawada1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24283600      PMCID： PMC8033819          DOI： 10.1111/jch.12183

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  9 in total

Review 1.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

2.  Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial.

Authors:  Lourdes Lozano; José Luis Tovar; Gabriel Sampol; Odile Romero; María José Jurado; Alfons Segarra; Eugènia Espinel; José Ríos; María Dolores Untoria; Patrícia Lloberes
Journal:  J Hypertens       Date:  2010-10       Impact factor: 4.844

Review 3.  Resistant hypertension, obstructive sleep apnoea and aldosterone.

Authors:  T Dudenbostel; D A Calhoun
Journal:  J Hum Hypertens       Date:  2011-06-09       Impact factor: 3.012

4.  Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Carolina C Gonzaga; Marcio G Sousa; Lílian K G de Paula; Aline C S Amaro; Celso Amodeo; Luiz A Bortolotto; Eduardo M Krieger; T Douglas Bradley; Geraldo Lorenzi-Filho
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

Review 5.  How can resistant hypertension be identified and prevented?

Authors:  Anna Solini; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2013-03-05       Impact factor: 32.419

Review 6.  Aldosterone and the risk of hypertension.

Authors:  Vanessa Xanthakis; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

7.  Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism.

Authors:  Eduardo Pimenta; Michael Stowasser; Richard D Gordon; Susan M Harding; Michel Batlouni; Bin Zhang; Suzanne Oparil; David A Calhoun
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

8.  Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.

Authors:  K Gaddam; E Pimenta; S J Thomas; S S Cofield; S Oparil; S M Harding; D A Calhoun
Journal:  J Hum Hypertens       Date:  2009-12-17       Impact factor: 3.012

9.  Screening for severe obstructive sleep apnea syndrome in hypertensive outpatients.

Authors:  Indira Gurubhagavatula; Barry G Fields; Christian R Morales; Sharon Hurley; Grace W Pien; Lindsay C Wick; Bethany A Staley; Raymond R Townsend; Greg Maislin
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-12       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.